Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Shanghai Starts New Antibody Institute; Names US Researcher as Director

publication date: Oct 15, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Shanghai has established an institute for advanced immunochemical studies, sponsored by Shanghai Tech University and the Shanghai Advanced Research Institute under the Chinese Academy of Sciences. Its goal is to advance antibody drug R&D. Richard Lerner, MD, a research chemist who recently stepped down after twenty years as head of The Scripps Research Institute, was named the institute’s first director. Lerner will lead a team of experts from the US, Europe and China. More details....

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...